Acro Biomedical (ACBM) Common Equity (2015 - 2025)
Acro Biomedical's quarterly Common Equity came in at -$386964.0 in Q4 2025, down 31.19% year-on-year from -$562338.9 in Q4 2024, and up 10.55% quarter-over-quarter from -$432619.0 in Q3 2025.
Acro Biomedical has reported Common Equity for 11 years, with the latest figure at -$386964.0 in Q4 2025.
- For the quarter ending Q4 2025, Common Equity fell 31.19% year-over-year to -$386964.0; the trailing twelve-month figure through Dec 2025 stood at -$386964.0 (down 31.19% YoY), and the FY2025 full-year result was -$386964.0, down 31.19% from the prior year.
- Common Equity for Q4 2025 stood at -$386964.0, up from -$432619.0 in the prior quarter.
- The five-year high for Common Equity was $643707.0 in Q4 2021, with the low at -$432619.0 in Q3 2025.
- Average Common Equity over 5 years is $118319.2, with a median of $50020.5 recorded in 2023.
- Year-over-year, Common Equity grew 2.28% in 2022 and sank 181.38% in 2024.
- Tracing ACBM's Common Equity over 5 years: stood at $643707.0 in 2021, then slipped by 24.44% to $486370.0 in 2022, then slumped by 152.84% to -$257014.0 in 2023, then decreased by 14.77% to -$294972.0 in 2024, then sank by 31.19% to -$386964.0 in 2025.
- The last three Common Equity figures came in at -$386964.0 (Q4 2025), -$432619.0 (Q3 2025), and -$317520.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | -16.30 Mn |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | -12.19 Mn |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | -13.79 Mn |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | -11.23 Mn |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | -29.19 Mn |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | -16.14 Mn |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | -8.10 Mn |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | -14.01 Mn |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | -8.10 Mn |
| 10 | Acro Biomedical | - | - | - | -386,964.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -386,964.00 |
| Sep 30, 2025 | -432,619.00 |
| Jun 30, 2025 | -317,520.00 |
| Mar 31, 2025 | -303,906.00 |
| Dec 31, 2024 | -294,972.00 |
| Sep 30, 2024 | -285,504.00 |
| Jun 30, 2024 | -276,398.00 |
| Mar 31, 2024 | -267,312.00 |
| Dec 31, 2023 | -257,014.00 |
| Sep 30, 2023 | -239,613.00 |
| Jun 30, 2023 | 339,654.00 |
| Mar 31, 2023 | 410,904.00 |
| Dec 31, 2022 | 486,370.00 |
| Sep 30, 2022 | 492,164.00 |
| Jun 30, 2022 | 574,887.00 |
| Mar 31, 2022 | 643,219.00 |
| Dec 31, 2021 | 643,707.00 |
| Sep 30, 2021 | 568,218.00 |
| Jun 30, 2021 | 640,207.00 |
| Mar 31, 2021 | 628,877.00 |
| Dec 30, 2020 | 685,868.00 |
| Sep 30, 2020 | 745,484.00 |
| Jun 30, 2020 | 817,025.00 |
| Mar 31, 2020 | 879,796.00 |
| Dec 31, 2019 | 798,239.00 |
| Sep 30, 2019 | 873,672.00 |
| Jun 30, 2019 | 948,003.00 |
| Mar 31, 2019 | 998,218.00 |
| Dec 31, 2018 | 1.17 Mn |
| Sep 30, 2018 | 1.24 Mn |
| Jun 30, 2018 | 777,319.00 |
| Mar 31, 2018 | 661,010.00 |
| Dec 31, 2017 | 591,558.00 |
| Sep 30, 2017 | 511,331.00 |
| Jun 30, 2017 | -28,164.00 |
| Mar 31, 2017 | -16,277.00 |
| Dec 31, 2016 | -22,206.00 |
| Sep 30, 2016 | -14,793.00 |
| Jun 30, 2016 | -8,666.00 |
| Mar 31, 2016 | 8,459.00 |
| Sep 30, 2015 | 28,635.00 |